Carnitine: Transport and physiological functions in the brain

Molecular Aspects of Medicine

Volumn 25, Issue 5-6, 2004, Pages 551-567

  Nałȩcz, Katarzyna A ^a   Miecz, Dorota ^a   Berezowski, Vincent ^b   Cecchelli, Roméo ^b  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UNIVERSITÉ D'ARTOIS   (France)

Author keywords

B0,+; Carnitine; OCTN2; Palmitoylation; Protein kinase C

Indexed keywords

ACETYLCARNITINE; CARNITINE; PALMITOYLCARNITINE;

AMINO ACID TRANSPORT; BRAIN CORTEX; BRAIN FUNCTION; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; MENTAL DETERIORATION; MULTIPLE SCLEROSIS; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

EID: 4444372351     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2004.06.001     Document Type: Article

References (130)

1. Abbas A.S., Wu G., Schulz H. Carnitine acetyltransferase is not a cytosolic enzyme in rat heart and therefore cannot function in the energy-linked regulation of cardiac fatty acid oxidation. J. Mol. Cell Cardiol. 30:1998;1305-1309
2. 2+ transport. J. Biol. Chem. 254:1979;12404-12410
3. Allen D.D., Smith Q.R. Blood-brain barrier choline transport in the senescent rat. Neurosci. Lett. 277:1999;198-202
4. Arduini A., Denisova N., Virmani A., Avrova N., Federici G., Arrigoni-Martelli E. Evidence for the involvement of carnitine-dependent long-chain acyltransferases in neuronal triglyceride and phospholipid fatty acid turnover. J. Neurochem. 62:1994;1530-1538
5. Athanassakis I., Zarifi I., Evangeliou A., Vassiliadis S. L-Carnitine accelerates the in vitro regeneration of neural network from adult murine brain cells. Brain Res. 932:2002;70-78
6. 0,+ in the transport of carnitine through the blood-brain barrier. Submitted for publication
7. Bird M.I., Munday L.A., Saggerson E.D., Clark J.B. Carnitine acyltransferase activities in rat brain mitochondria. Bimodal distribution, kinetic constants, regulation by malonyl-CoA and developmental pattern. Biochem. J. 226:1985;323-330
8. Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int. J. Clin. Pharmacol. Therm. Toxicol. 24:1986;511-516
9. Bouzier-Sore A.K., Voisin P., Canioni P., Magistretti P.J., Pellerin L. Lactate is a preferential oxidative energy substrate over glucose for neurons in culture. J. Cereb. Blood Flow Metab. 23:2003;1298-1306
10. Bresolin N., Freddo L., Vergani L., Angelini C. Carnitine, carnitine acyltransferases, and rat brain function. Exp. Neurol. 78:1982;285-292
11. Cai Y., Cronin C.N., Engel A.G., Ohno K., Hersh L.B., Rodgers D.W. Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders. EMBO J. 23:2004;2047-2058
12. Calabrese V., Scapagnini G., Ravagna A., Bella R., Butterfield D.A., Calvani M., Pennisi G., Giuffrida Stella A.M. Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine. Neurochem. Res. 28:2003;1321-1328
13. Cecchelli R., Dehouck B., Descamps L., Fenart L., Buee-Scherrer V.V., Duhem C., Lundquist S., Rentfel M., Torpier G., Dehouck M.P. In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Deliv. Rev. 36:1999;165-178
14. Degtyarev M.Y., Spiegel A.M., Jones T.L. Palmitoylation of a G protein alpha i subunit requires membrane localization not myristoylation. J. Biol. Chem. 269:1994;30898-30903
15. di San Filippo C.A., Wang Y., Longo N. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency. J. Biol. Chem. 278:2003;47776-47784
16. Dobransky T., Rylett R.J. Functional regulation of choline acetyltransferase by phosphorylation. Neurochem. Res. 28:2003;537-542
17. Doležal V., Tuček S. Utilization of citrate, acetylcarnitine, acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slices. J. Neurochem. 36:1981;1323-1330
18. Duelli R., Enerson B.E., Gerhart D.Z., Drewes L.R. Expression of large amino acid transporter LAT1 in rat brain endothelium. J. Cereb. Blood Flow Metab. 20:2000;1557-1562
19. 13C nuclear magnetic resonance spectroscopy. J. Neurosci. 23:2003;5928-5935
20. Elfeber K., Kohler A., Lutzenburg M., Osswald C., Galla H.J., Witte O.W., Koepsell H. Localization of the Na(+)-d-glucose cotransporter SGLT1 in the blood-brain barrier. Histochem. Cell Biol. 121:2004;201-207
21. Ennis S.R., Kawai N., Ren X.D., Abdelkarim G.E., Keep R.F. Glutamine uptake at the blood-brain barrier is mediated by N-system transport. J. Neurochem. 71:1998;2565-2573
22. Enomoto A., Wempe M.F., Tsuchida H., Shin H.J., Cha S.H., Anzai N., Goto A., Sakamoto A., Niwa T., Kanai Y., Anders M.W., Endou H. Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J. Biol. Chem. 277:2002;36262-36271
23. Estrada C., Bready J., Berliner J., Cancilla P.A. Choline uptake by cerebral capillary endothelial cells in culture. J. Neurochem. 54:1990;1467-1473
24. Falchetto S., Kato G., Provini L. The action of carnitines on cortical neurons. Can. J. Physiol. Pharmacol. 49:1971;1-7
25. Fariello R.G., Shug A.L. Competitive inhibition by 3-aminopropanesulfonic acid and gamma-aminobutyric acid of carnitine transport in rat brain slices. Biochem. Pharmacol. 30:1981;1012-1013
26. Farrell C.L., Pardridge W.M. Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc. Natl. Acad. Sci. USA. 88:1991;5779-5783
27. Forloni G., Angeretti N., Smiroldo S. Neuroprotective activity of acetyl-L-carnitine: studies in vitro. J. Neurosci. Res. 37:1994;92-96
28. Friedrich A., George R.L., Bridges C.C., Prasad P.D., Ganapathy V. Transport of choline and its relationship to the expression of the organic cation transporters in a rat brain microvessel endothelial cell line (RBE4). Biochim. Biophys. Acta. 1512:2001;299-307
29. Gabrielle P., Jeana M., Lorenza E.C. Cytosolic choline acetyltransferase binds specifically to cholinergic plasma membrane of rat brain synaptosomes to generate membrane-bound enzyme. Neurochem. Res. 28:2003;543-559
30. Galea E., Estrada C. Ouabain-sensitive choline transport system in capillaries isolated from bovine brain. J. Neurochem. 59:1992;936-941
31. Ganapathy M.E., Huang W., Rajan D.P., Carter A.L., Sugawara M., Iseki K., Leibach F.H., Ganapathy V. β-Lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J. Biol. Chem. 275:2000;1699-1707
32. Gao B., Stieger B., Noe B., Fritschy J.M., Meier P.J. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J. Histochem. Cytochem. 47:1999;1255-1264
33. Gerhart D.Z., Enerson B.E., Zhdankina O.Y., Leino R.L., Drewes L.R. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am. J. Physiol. 273:1997;E207-213
34. Gibson G.E., Shimada M. Studies on the metabolic pathway of the acetyl group for acetylcholine synthesis. Biochem. Pharmacol. 29:1980;167-174
35. Goodman D.R., Adatsi F.K., Harbison R.D. Evidence for the extreme overestimation of choline acetyltransferase in human sperm, human seminal plasma and rat heart: a case of mistaking carnitine acetyltransferase for choline acetyltransferase. Chem. Biol. Interact. 49:1984;39-53
36. Hannuniemi R., Kontro P. L-Carnitine uptake by mouse brain synaptosomal preparations: competitive inhibition by GABA. Neurochem. Res. 13:1988;317-323
37. Haruna T., Horie M., Takano M., Kono Y., Yoshida H., Otani H., Kubota T., Ninomiya T., Akao M., Sasayama S. Alteration of the membrane lipid environment by L-palmitoylcarnitine modulates K(ATP) channels in guinea-pig ventricular myocytes. Pflugers Arch. 441:2000;200-207
38. Hosoya K., Tomi M., Ohtsuki S., Takanaga H., Saeki S., Kanai Y., Endou H., Naito M., Tsuruo T., Terasaki T. Enhancement of L-cystine transport activity and its relation to xCT gene induction at the blood-brain barrier by diethyl maleate treatment. J. Pharmacol. Exp. Ther. 302:2002;225-231
39. Huth P.J., Schmidt M.J., Hall P.V., Fariello R.G., Shug A.L. The uptake of carnitine by slices of rat cerebral cortex. J. Neurochem. 36:1981;715-723
40. Inano A., Sai Y., Nikaido H,, Hasimoto N., Asano M., Tsuji A., Tamai I. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2. Biopharm. Drug Dispos. 24:2003;357-365
41. Jogl G., Tong L. Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport. Cell. 112:2003;113-122
42. Kalaria R.N., Harik S.I. Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease. Ann. Neurol. 32:1992;583-586
43. Kamińska J., Nalecz K.A., Nalecz M.J. Mechanism of carnitine transport catalyzed by carnitine carrier from rat brain mitochondria. Acta Neurobiol. Exp. (Wars.). 55:1995;1-9
44. Kang Y.S., Ohtsuki S., Takanaga H., Tomi M., Hosoya K., Terasaki T. Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-alpha, taurine and hypertonicity. J. Neurochem. 83:2002;1188-1195
45. Kerner J., Hoppel C. Fatty acid import into mitochondria. Biochim. Biophys. Acta. 1486:2000;1-17
46. Kido Y., Tamai I., Okamoto M., Suzuki F., Tsuji A. Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharm. Res. 17:2000;55-62
47. Kido Y., Tamai I., Ohnari A., Sai Y., Kagami T., Nezu J., Nikaido H., Hashimoto N., Asano M., Tsuji A. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J. Neurochem. 79:2001;959-969
48. Koizumi T., Nikaido H., Hayakawa J., Nonomura A., Yoneda T. Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2(0) strain of mouse with similarities to Reye's syndrome. Lab. Anim. 22:1988;83-87
49. Komura J., Tamai I., Senmaru M., Terasaki T., Sai Y., Tsuji A. Sodium and chloride ion-dependent transport of beta-alanine across the blood-brain barrier. J. Neurochem. 67:1996;330-335
50. Komura J., Tamai I., Senmaru M., Terasaki T., Sai Y., Tsuji A. Brain-to-blood active transport of beta-alanine across the blood-brain barrier. FEBS Lett. 400:1997;131-135
51. Lavrentyev E.N., Matta S.G., Cook G.A. Expression of three carnitine palmitoyltransferase-I isoforms in 10 regions of the rat brain during feeding, fasting, and diabetes. Biochem. Biophys. Res. Commun. 315:2004;174-178
52. Lee W.J., Hawkins R.A., Vina J.R., Peterson D.R. Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal. Am. J. Physiol. 274:1998;C1101-C1107
53. Leino R.L., Gerhart D.Z., Drewes L.R. Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Brain Res. Dev. Brain Res. 113:1999;47-54
54. Leino R.L., Gerhart D.Z., Duelli R., Enerson B.E., Drewes L.R. Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem. Int. 38:2001;519-527
55. + nucleoside cotransporter CNT2. J. Cereb. Blood Flow Metab. 21:2001;929-936
56. Liu Q.R., Lopez-Corcuera B., Mandiyan S., Nelson H., Nelson N. Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain. J. Biol. Chem. 268:1993;2106-2112
57. Liu Q.Y., Rosenberg R.L. Activation and inhibition of reconstituted cardiac L-type calcium channels by palmitoyl-L-carnitine. Biochem. Biophys. Res. Commun. 228:1996;252-258
58. Llansola M., Erceg S., Hernandez-Viadel M., Felipo V. Prevention of ammonia and glutamate neurotoxicity by carnitine: molecular mechanisms. Metab. Brain Dis. 17:2002;389-397
59. Lockman P.R., Mumper R.J., Allen D.D. Evaluation of blood-brain barrier thiamine efflux using the in situ rat brain perfusion method. J. Neurochem. 86:2003;627-634
60. Magistretti P.J., Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 354:1999;1155-1163
61. Matsuo H., Tsukada S., Nakata T., Chairoungdua A., Kim D.K., Cha S.H., Inatomi J., Yorifuji H., Fukuda J., Endou H., Kanai Y. Expression of a system L neutral amino acid transporter at the blood-brain barrier. Neuroreport. 11:2000;3507-3511
62. Mizgalska J., Berent U., Mac M., Oestreicher A., De Graan P., Gispen W., Nalecz M., Nalecz K. Accumulation of palmitoylcarnitine in neuroblastoma NB-2a cells affects expression, phosphorylation and localization of B-50 protein. Neurosci. Res. Com. 22:1998;73-81
63. Mroczkowska J.E., Roux F.S., Galla H.J., Nalecz M.J., Nalecz K.A. Transport of carnitine in RBE4 cells - an in vitro model of blood-brain barrier. Neurosci. Res. Com. 19:1996;153-160
64. Mroczkowska J.E., Galla H.J., Nalecz M.J., Nalecz K.A. Evidence for an asymmetrical uptake of L-carnitine in the blood-brain barrier in vitro. Biochem. Biophys. Res. Commun. 241:1997;127-131
65. Mroczkowska J.E., Roux F.S., Nalecz M.J., Nalecz K.A. Blood-brain barrier controls carnitine level in the brain: a study on a model system with RBE4 cells. Biochem. Biophys. Res. Commun. 267:2000;433-437
66. Muraki K., Imaizumi Y. A novel action of palmitoyl-L-carnitine in human vascular endothelial cells. J. Pharmacol. Sci. 92:2003;252-258
67. Mutomba M.C., Yuan H., Konyavko M., Adachi S., Yokoyama C.B., Esser V., McGarry J.D., Babior B.M., Gottlieb R.A. Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine. FEBS Lett. 478:2000;19-25
68. --coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J. Physiol. 532:2001;297-304
69. Nalecz K.A., Korzon D., Wawrzeńczyk A., Nalecz M.J. Transport of carnitine in neuroblastoma NB-2a cells. Arch. Biochem. Biophys. 322:1995;214-220
70. Nalecz K.A., Mroczkowska J.E., Berent U., Nalecz M.J. Effect of palmitoylcarnitine on the cellular differentiation, proliferation and protein kinase C activity in neuroblastoma nb-2a cells. Acta Neurobiol. Exp. (Wars.). 57:1997;263-274
71. Nehlig A., Pereira de Vasconcelos A. Glucose and ketone body utilization by the brain of neonatal rats. Prog. Neurobiol. 40:1993;163-221
72. - neurotransmitter transporters. J. Neurochem. 71:1998;1785-1803
73. Ohtsuki S., Tachikawa M., Takanaga H., Shimizu H., Watanabe M., Hosoya K., Terasaki T. The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J. Cereb. Blood Flow Metab. 22:2002;1327-1335
74. O'Kane R.L., Martinez-Lopez I., DeJoseph M.R., Vina J.R., Hawkins R.A. Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J. Biol. Chem. 274:1999;31891-31895
75. Pardridge W.M., Sakiyama R., Coty W.A. Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J. Neurochem. 44:1985;1138-1141
76. Pardridge W.M., Boado R.J., Farrell C.R. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J. Biol. Chem. 265:1990;18035-18040
77. Price N., van der Leij F., Jackson V., Corstorphine C., Thomson R., Sorensen A., Zammit V. A novel brain-expressed protein related to carnitine palmitoyltransferase I. Genomics. 80:2002;433-442
78. Ramsay R.R. The carnitine acyltransferases: modulators of acyl-CoA-dependent reactions. Biochem. Soc. Trans. 28:2000;182-186
79. Ričny J., Tuček S., Novakova J. Acetylcarnitine, carnitine and glucose diminish the effect of muscarinic antagonist quinuclidinyl benzilate on striatal acetylcholine content. Brain Res. 576:1992;215-219
80. Robinson P.J. Potencies of protein kinase C inhibitors are dependent on the activators used to stimulate the enzyme. Biochem. Pharmacol. 44:1992;1325-1334
81. Rubio J.C., de Bustos F., Molina J.A., Jimenez-Jimenez F.J., Benito-Leon J., Martin M.A., Campos Y., Orti-Pareja M., Cabrera-Valdivia F., Arenas J. Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease. J. Neurol. Sci. 155:1998;192-195
82. Sawada N., Takanaga H., Matsuo H., Naito M., Tsuruo T., Sawada Y. Choline uptake by mouse brain capillary endothelial cells in culture. J. Pharm. Pharmacol. 51:1999;847-852
83. Scaglia F., Longo N. Primary and secondary alterations of neonatal carnitine metabolism. Semin. Perinatol. 23:1999;152-161
84. Scaglia F., Wang Y., Longo N. Functional characterization of the carnitine transporter defective in primary carnitine deficiency. Arch. Biochem. Biophys. 364:1999;99-106
85. Scheggi S., Rauggi R., Nanni G., Tagliamonte A., Gambarana C. Repeated acetyl-l-carnitine administration increases phospho-Thr34 DARPP-32 levels and antagonizes cocaine-induced increase in Cdk5 and phospho-Thr75 DARPP-32 levels in rat striatum. Eur. J. Neurosci. 19:2004;1609-1620
86. Schömig E., Spitzenberger F., Engelhardt M., Martel F., Örding N., Gründemann D. Molecular cloning and characterization of two novel transport proteins from rat kidney. FEBS Lett. 425:1998;79-86
87. Sekine T., Kusuhara H., Utsunomiya-Tate N., Tsuda M., Sugiyama Y., Kanai Y., Endou H. Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine. Biochem. Biophys. Res. Commun. 251:1998;586-591
88. Sha D., Jin H., Kopke R.D., Wu J.Y. Choline acetyltransferase: regulation and coupling with protein kinase and vesicular acetylcholine transporter on synaptic vesicles. Neurochem. Res. 29:2004;199-207
89. Shen J.B., Pappano A.J. Palmitoyl-L-carnitine acts like ouabain on voltage, current, and contraction in guinea pig ventricular cells. Am. J. Physiol. 268:1995;H1027-36
90. Shinawi M., Gruener N., Lerner A. CSF levels of carnitine in children with meningitis, neurologic disorders, acute gastroenteritis, and seizure. Neurology. 50:1998;1869-1871
91. Slavikova J., Tuček S. Choline acetyltransferase in the heart of adult rats. Pflugers Arch. 392:1982;225-229
92. Sloan J.L., Mager S. Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). J. Biol. Chem. 274:1999;23740-23745
93. Sobiesiak-Mirska J., Nalecz K.A. Palmitoylcarnitine modulates interaction protein kinase C delta-GAP-43. Biochem. Biophys. Res. Commun. 294:2002;823-828
94. Sobiesiak-Mirska J., Nalecz M.J., Nalecz K.A. Interaction of palmitoylcarnitine with protein kinase C in neuroblastoma NB-2a cells. Neurochem. Int. 42:2003;45-55
95. Spagnoli A., Lucca U., Menasce G., Bandera L., Cizza G., Forloni G., Tettamanti M., Frattura L., Tiraboschi P., Comelli M. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology. 41:1991;1726-1732
96. Spector R. Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J. Neurochem. 53:1989;1667-1674
97. Sterling G.H., O'Neill J.J. Citrate as the precursor of the acetyl moiety of acetylcholine. J. Neurochem. 31:1978;525-530
98. 0 is a major growth cone protein subject to regulation by GAP-43. Nature. 344:1990;836-841
99. Supplisson S., Roux M.J. Why glycine transporters have different stoichiometries. FEBS Lett. 529:2002;93-101
100. Suzdak P.D., Frederiksen K., Andersen K.E., Sorensen P.O., Knutsen L.J., Nielsen E.B. NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization. Eur. J. Pharmacol. 224:1992;189-198
101. Swiegers J.H., Dippenaar N., Pretorius I.S., Bauer F.F. Carnitine-dependent metabolic activities in Saccharomyces cerevisiae: three carnitine acetyltransferases are essential in a carnitine-dependent strain. Yeast. 18:2001;585-595
102. Szczepankowska D., Nalecz K.A. Palmitoylcarnitine modulates palmitoylation of proteins: implication for differentiation of neural cells. Neurochem. Res. 28:2003;645-651
103. Takanaga H., Tokuda N., Ohtsuki S., Hosoya K., Terasaki T. ATA2 is predominantly expressed as system A at the blood-brain barrier and acts as brain-to-blood efflux transport for L-proline. Mol. Pharmacol. 61:2002;1289-1296
104. Tamai I., Yabuuchi H., Nezu J., Sai Y., Oku A., Shimane M., Tsuji A. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 419:1997;107-111
105. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., Sai Y., Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273:1998;20378-20382
106. Tamai I., Ohashi R., Nezu J.I., Sai Y., Kobayashi D., Oku A., Shimane M., Tsuji A. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J. Biol. Chem. 275:2000;40064-40072
107. Tanaka M., Nakamura F., Mizokawa S., Matsumura A., Matsumura K., Watanabe Y. Role of acetyl-L-carnitine in the brain: revealed by Bioradiography. Biochem. Biophys. Res. Commun. 306:2003;1064-1069
108. Thomas S.A., Segal M.B. Saturation kinetics, specificity and NBMPR sensitivity of thymidine entry into the central nervous system. Brain Res. 760:1997;59-67
109. Tomi M., Hosoya K., Takanaga H., Ohtsuki S., Terasaki T. Induction of xCT gene expression and L-cystine transport activity by diethyl maleate at the inner blood-retinal barrier. Invest. Ophthalmol. Vis. Sci. 43:2002;774-779
110. Tsuji A., Tamai I.I. Carrier-mediated or specialized transport of drugs across the blood-brain barrier. Adv. Drug Deliv. Rev. 36:1999;277-290
111. Tuček S., Cheng S.C. Precursors of acetyl groups in acetylcholine in the brain in vivo. Biochim. Biophys. Acta. 208:1970;538-540
112. Tuček S., Cheng S.C. Provenance of the acetyl group of acetylcholine and compartmentation of acetyl-CoA and Krebs cycle intermediates in the brain in vivo. J. Neurochem. 22:1974;893-914
113. Tuček S., Doležal V., Sullivan A.C. Inhibition of the synthesis of acetylcholine in rat brain slices by (-)-hydroxycitrate and citrate. J. Neurochem. 36:1981;1331-1337
114. Tuček S., Ričny J., Doležal V. Acetylcoenzyme A and the control of the synthesis of acetylcholine in the brain. Acta Neurobiol. Exp. (Wars.). 42:1982;59-68
115. Tuček S. Acetylcoenzyme A and the synthesis of acetylcholine in neurones: review of recent progress. Gen. Physiol. Biophys. 2:1983;313-324
116. Tuček S. Regulation of acetylcholine synthesis in the brain. J. Neurochem. 44:1985;11-24
117. Tuček S. The synthesis of acetylcholine: twenty years of progress. Prog. Brain Res. 84:1990;467-477
118. Wakayama K., Ohtsuki S., Takanaga H., Hosoya K., Terasaki T. Localization of norepinephrine and serotonin transporter in mouse brain capillary endothelial cells. Neurosci. Res. 44:2002;173-180
119. Wakim B.T., Alexander K.A., Masure H.R., Cimler B.M., Storm D.R., Walsh K.A. Amino acid sequence of P-57, a neurospecific calmodulin-binding protein. Biochemistry. 26:1987;7466-7470
120. Warshaw J.B., Terry M.L. Cellular energy metabolism during fetal development. VI. Fatty acid oxidation by developing brain. Dev. Biol. 52:1976;161-166
121. Wawrzeńczyk A., Nalecz K.A., Nalecz M.J. Synergistic effect of choline and carnitine on acetylcholine synthesis in neuroblastoma NB-2a cells. Biochem. Biophys. Res. Commun. 202:1994;354-359
122. Wawrzeńczyk A., Nalecz K.A., Nalecz M.J. Effect of gamma-aminobutyric acid on the carnitine metabolism in neural cells. Biochem. Biophys. Res. Commun. 213:1995;383-388
123. Wawrzeńczyk A., Nalecz K.A., Nalecz M.J. Effect of externally added carnitine on the synthesis of acetylcholine in rat cerebral cortex cells. Neurochem. Int. 26:1995;635-641
124. Wawrzeńczyk A., Sacher A., Mac M., Nalecz M.J., Nalecz K.A. Transport of L-carnitine in isolated cerebral cortex neurons. Eur. J. Biochem. 268:2001;2091-2098
125. White H.L., Scates P.W. Acetyl-L-carnitine as a precursor of acetylcholine. Neurochem. Res. 15:1990;597-601
126. Wu X., Prasad P.D., Leibach F.H., Ganapathy V. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem. Biophys. Res. Commun. 246:1998;589-595
127. Wu X., Huang W., Prasad P.D., Seth P., Rajan D.P., Leibach F.H., Chen J., Conway S.J., Ganapathy V. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J. Pharmacol. Exp. Ther. 290:1999;1482-1492
128. Wu X., George R.L., Huang W., Wang H., Conway S.J., Leibach F.H., Ganapathy V. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim. Biophys. Acta. 1466:2000;315-327
129. Xuan W., Lamhonwah A.M., Librach C., Jarvi K., Tein I. Characterization of organic cation/carnitine transporter family in human sperm. Biochem. Biophys. Res. Commun. 306:2003;121-128
130. Zoccarato F., Siliprandi N., Rugolo M. Studies on the transport of carnitine in the brain using synaptosomes isolated from guinea-pig cerebral cortex. Biochim. Biophys. Acta. 734:1983;381-383